The Daily Caller reports the priority policy is pending sign-off from the White House, following FDA action on six peptide drugs.
Recap by typeshit. Full story at The Daily Caller on MSN.
A general explainer on how GLP-1 receptor agonists affect blood sugar and appetite, with advice on support while taking them.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
Among the items: Walmart plans free GLP-1 diabetes drugs for employees in 2027, and Verdiva Bio dropped a phase II oral GLP-1 study citing market changes.
Longevity Technology reports BodySpec's new offering targets GLP-1 users worried about muscle, with body scans said to take about 12 minutes.
TCTMD reports that two novel incretin-based agents looked highly effective in type 2 diabetes across a pair of new studies.
MedPage Today
Among about 7,100 pregnant women with migraine, early exposure to drugs like Aimovig was linked to more miscarriages, while propranolol showed no added risk.
Loading…